Pustulosis palmoplantar inducida por certolizumab pegol: presentación de un caso y revisión de la literatura

Villalobos-Sánchez, Lourdes; Larena-Grijalba, Carmen; Alía-Jiménez, Adela; Sifuentes-Giraldo, Walter Alberto.
Reumatol. clín. (Barc.) ; 15(6): e163-e165, nov.-dic. 2019. ilus, tab
Artículo en Español | IBECS (España) | ID: ibc-190176

Documentos relacionados

  1. Certolizumab pegol-induced palmoplantar pustulosis: A case report and review of the literature.
  2. Certolizumab-induced guttate psoriasiform dermatitis.
  3. Certolizumab Pegol in Plaque Psoriasis: Considerations for Pregnancy.
  4. Bullous acral eruption related to secukinumab.
  5. Certolizumab pegol for maintenance of medically induced remission in Crohn's disease.
  6. Efficacy and safety of certolizumab pegol in pregnant women with uveitis. Recommendations on the management with immunosuppressive and biologic therapies in uveitis during pregnancy.
  7. Three-year efficacy and safety of certolizumab pegol for the treatment of plaque psoriasis: results from the randomized phase 3 CIMPACT trial.
  8. Psoriasiform skin eruption in a patient receiving certolizumab-pegol for ankylosing spondylitis: Report of a case and review of the literature.
  9. Psoriasis and pregnancy in the biologic era, a feared scenario. What do we do now?
  10. Certolizumab pegol for the treatment of patients with moderate-to-severe chronic plaque psoriasis: pooled analysis of week 16 data from three randomized controlled trials.